← Back to headlines
Ardelyx Chief Patient Officer Executes $41,419 Stock Sale
The chief patient officer at biotech firm Ardelyx has sold shares valued at $41,419, according to recent SEC filings.
26 Aug, 02:00 — 26 Aug, 02:00
Sources
Showing 1 of 1 sources
